![Camille Landis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Camille Landis worked as the Vice President of Business Development at Relypsa, Inc. from 2015 to 2017.
Prior to that, she was the Senior Vice President of Corporate Development at Unity Biotechnology, Inc. and the Chief Business Officer at Eidos Therapeutics, Inc. Ms. Landis received an undergraduate degree from the University of St. Thomas and an MBA from the Haas School of Business.
Anciens postes connus de Camille Landis
| Sociétés | Poste | Fin |
|---|---|---|
| EIDOS THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2018 |
| RELYPSA INC | Corporate Officer/Principal | 01/08/2017 |
| UNITY BIOTECHNOLOGY, INC. | Corporate Officer/Principal | - |
Formation de Camille Landis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
36
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of St. Thomas
 University of St. Thomas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unity Biotechnology, Inc.
 Unity Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for osteoarthritis, eye and pulmonary diseases | Health Technology |
Eidos Therapeutics, Inc.
 Eidos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
